Phosphatidylserine can make your stiff arteries chill out
Discover how phosphatidylserine, a nutrient in foods like white beans and mackerel, may help restore youthful artery flexibility and contribute to resetting ins
By Foodie Pundit Newsroom - Published - Updated - Section: Health Nutrition

Key points
- Phosphatidylserine (PS), a natural fat molecule, may protect blood vessels by inhibiting a rogue enzyme called ADAM17 that may damage insulin receptors.
- In a clinical trial, PS supplementation appeared to help improve blood flow and reduce artery stiffness in individuals with Type 2 Diabetes.
- PS is suggested to work as a 'dual-action' nutrient: it may help restore the vascular system's sensitivity to insulin while also acting as an antioxidant to reduce cellular damage.
- You can increase your intake of phosphatidylserine through foods like Atlantic mackerel, white beans, and soy lecithin.
- Combining PS-rich foods with sources of omega-3 fats (like avocado and olive oil) may create a powerful synergy for building healthy, flexible cell membranes throughout your body.
It's one of the biggest paradoxes in modern wellness. You might be crushing your health goals: swapping sugar for monk fruit, diligently tracking your macros, maybe even brewing your own kombucha. Yet, lurking beneath the surface, a silent process could be contributing to your arteries aging before their time.
For millions dealing with the metabolic challenges of type 2 diabetes, this can be a daily reality. The very hormone meant to usher energy into your cells, insulin, can start getting ignored by the one place you need it most: the delicate lining of your blood vessels. Now, a study from the Journal of Applied Physiology is pointing to a powerful nutrient that might offer support in reclaiming vascular health.
Researchers recently explored that a specific nutrient, phosphatidylserine (or PS for short), may have a remarkable ability to shield arteries from damage associated with "endothelial insulin resistance." This condition is a core feature of type 2 diabetes, potentially leading to a cascade of problems: reduced production of nitric oxide (the molecule that tells your arteries to relax and widen), impaired blood flow (vasodilation), and a progressive stiffening of major arteries. Think of it like a brand-new garden hose left out in the sun; it loses its flexibility and becomes rigid and prone to cracking. This arterial stiffness is a major factor in cardiovascular risk.
The research team, led by McMillan et al., identified a key enzyme implicated in this process: ADAM17. In the context of diabetes, ADAM17 can become overactive, potentially acting like a tiny pair of scissors that snips off insulin receptors from the surface of endothelial cells.
Without these crucial docking stations, insulin may not deliver its message effectively, and the vascular system could be affected. The scientists hypothesized that if they could inhibit ADAM17, they might protect those precious receptors and support healthy vascular function. Their potential tool?
Phosphatidylserine, a natural phospholipid that earlier research suggested could competitively inhibit this very enzyme. The results indicated that oral PS supplementation managed to enhance leg blood flow and reduce arterial stiffness in human participants with T2D.
From a functional medicine standpoint, this study offers insights into potential root causes. Conventional medicine often approaches T2D with a symptom-management toolkit focused on lowering blood sugar with pharmaceuticals. This could be likened to constantly mopping up a flooded bathroom without ever addressing the source of the overflow.
The Food is Medicine approach, however, asks why the issue is occurring in the first place. Why might blood vessels become resistant to insulin? What is the underlying biological process driving the dysfunction?
This research focuses on that "why": the potentially hyperactive ADAM17 enzyme. By identifying this upstream trigger, it may be possible to move beyond simply managing downstream symptoms. The potential benefit of using phosphatidylserine is that it isn't a blunt instrument; it is presented as a highly specific, bio-intelligent molecule that targets a key pathological mechanism.
It's not solely about forcing a number down; it's about supporting the body's innate signaling pathways. This is the core philosophy of functional nutrition: food isn't just fuel, it's information. Every bite sends a message to your genes, your cells, and your enzymes.
In this case, PS is suggested to deliver a clear message to ADAM17: "stand down."
Furthermore, the study highlights two critical functional imbalances that are often linked: insulin signaling and systemic inflammation (which drives oxidative stress). Insulin resistance may not happen in a vacuum. It can be fueled by chronic inflammation, which in turn generates a firestorm of free radicals (oxidative stress).
These free radicals can damage the endothelium, further impairing its ability to respond to insulin and produce nitric oxide. It can become a cycle. The researchers found that PS didn't just improve insulin signaling; it also appeared to reduce vascular oxidative stress.
This dual action is considered a significant aspect of functional interventions. It aims not just to address one issue; it seeks to upgrade the entire system to be more resilient and self-regulating.
So what exactly is phosphatidylserine? It's a phospholipid, which means it's a type of fat molecule that contains phosphorus. It is a critical component of every single cell membrane in your body, acting as a gatekeeper that controls what gets in and out.
But it's particularly concentrated in the brain, where it plays a vital role in neuronal communication. While it's often associated with cognitive health and focus, this new research firmly positions it in the realm of metabolic and cardiovascular support.
The mechanism of PS is suggested to be in its ability to modulate cell signaling. As this study shows, its primary mechanism of action here is as a competitive inhibitor of the ADAM17 enzyme. Imagine a game of musical chairs.
When ADAM17 is running rampant, it can find a chair (an insulin receptor) to interact with. PS is proposed to work by flooding the room with decoy chairs. It may bind to ADAM17, occupying its active site and potentially preventing it from ever reaching the insulin receptors on your blood vessel walls.
This simple, elegant act of interception aims to preserve the endothelium's sensitivity to insulin.
But that's not all. PS also acts as a potent antioxidant, helping to quench the fires of oxidative stress that can be damaging in a diabetic state. This is crucial for protecting nitric oxide, the master vasodilator.
Oxidative stress can rapidly degrade nitric oxide, taking it out of commission. By neutralizing free radicals, PS aims to protect your nitric oxide supply, allowing your blood vessels to relax, dilate, and function as they should.
When it comes to bioavailability, what you eat isn't what you absorb. The body can synthesize its own PS, but dietary intake becomes more important with age and under physiological stress, like that associated with T2D. When consumed, PS is readily absorbed in the small intestine.
Sources and methodology
Reported from primary records. Open any source to verify a claim.